$0.73
-0.14 (-15.99%)
Open$0.84
Previous Close$0.87
Day High$0.84
Day Low$0.73
52W High$2.02
52W Low$0.39
Volume—
Avg Volume22.36M
Market Cap11.14M
P/E Ratio—
EPS$-1.05
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 188.5K | 181.4K | 1.91M |
| Net Income | -7,541,656 | -6,530,828 | 328.9K |
| Profit Margin | -4,011.7% | -3,811.2% | 17.2% |
| EBITDA | -4,282,281 | -3,914,333 | 495.2K |
| Free Cash Flow | — | — | 411.8K |
| Rev Growth | +3.9% | +3.9% | -9.8% |
| Debt/Equity | 0.27 | 0.27 | 0.19 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |